Denmark
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 732.25 M
|
Dec. 31, 2023 | USD 216.88 | 1.28% |
|
Denmark |
|
2 |
USD 558.33 M
|
Dec. 31, 2023 | USD 54.16 | -1.39% |
|
Denmark |
|
3 |
USD 263.19 M
|
Dec. 31, 2023 | USD 26.62 | -0.36% |
|
Denmark |
|
4 |
USD 61.56 M
|
Dec. 31, 2023 | USD 131.57 | -1.84% |
|
Denmark |
|
5 |
USD 18.11 M
|
Dec. 31, 2023 | USD 95.84 | 0.08% |
|
Denmark |
|
6 |
USD 12.01 M
|
Dec. 31, 2023 | USD 91.43 | -1.85% |
|
Denmark |
|
7 |
USD 8.96 M
|
June 30, 2024 | USD 70.50 | 0.61% |
|
Denmark |
|
8 |
USD 489.35 K
|
Dec. 31, 2023 | USD 0.20 | -2.77% |
|
Denmark |
|
9 |
USD 249.32 K
|
Dec. 31, 2023 | USD 0.57 | 1.47% |
|
Denmark |
|
10 |
USD 0.00
|
Dec. 31, 2023 | USD 5.46 | 0.56% |
|
Denmark |
|
11 |
USD 0.00
|
Dec. 31, 2023 | USD 2.17 | 5.88% |
|
Denmark |
The Biotechnology company in Denmark with the highest Receivables is Genmab A/S (Copenhagen Stock Exchange: GMAB.CO) at USD 732.25 M.
The Biotechnology company in Denmark with the lowest Receivables is ExpreS2ion Biotech Holding AB (publ) (Stockholm Stock Exchange: EXPRS2.ST) at USD 0.00.
The top 10 Biotechnology companies in Denmark by Receivables are Genmab A/S, Novozymes A/S, Bavarian Nordic A/S, Ascendis Pharma A/S, Zealand Pharma A/S, Gubra A/S, ChemoMetec A/S, BioPorto A/S, Saniona AB (publ) and H. Lundbeck A/S.
The bottom 10 Biotechnology companies in Denmark by Receivables are ExpreS2ion Biotech Holding AB (publ), H. Lundbeck A/S, Saniona AB (publ), BioPorto A/S, ChemoMetec A/S, Gubra A/S, Zealand Pharma A/S, Ascendis Pharma A/S, Bavarian Nordic A/S and Novozymes A/S.